Assessing Carcinogenic Risk of PAH Mixtures Using Mechanism-Based Approaches

被引：0
|
作者：
Susan, Tilton C. [1 ]
Lisbeth, Siddens K. [1 ]
Christiane, Lohr, V [1 ]
Sharon, Krueger K. [1 ]
David, Williams E. [1 ]
William, Baird M. [1 ]
Katrina, Waters M. [2 ]
机构：
[1] Oregon State Univ, Corvallis, OR 97331 USA
[2] Pacific NW Natl Lab, Richland, WA 99352 USA
来源：
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS | 2015年 / 56卷
关键词：
D O I：
暂无
中图分类号：
X [环境科学、安全科学];
学科分类号：
08 ; 0830 ;
摘要：
P102
引用
收藏
页码：S82 / S82
页数：1
相关论文
共 50 条
  • [31] Mechanism-based cancer prevention approaches: Targets, examples, and the use of transgenic mice
    Hursting, SD
    Slaga, TJ
    Fischer, SM
    DiGiovanni, J
    Phang, JM
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (03): : 215 - 225
  • [32] Cancer Cachexia: Traditional Therapies and Novel Molecular Mechanism-Based Approaches to Treatment
    Nagi B. Kumar
    Aslam Kazi
    Tiffany Smith
    Theresa Crocker
    Daohai Yu
    Richard R. Reich
    Kiran Reddy
    Sally Hastings
    Martine Exterman
    Lodovico Balducci
    Kyle Dalton
    Gerold Bepler
    Current Treatment Options in Oncology, 2010, 11 : 107 - 117
  • [33] Informing and Validating Translational Mechanism-Based Models for Antibiotics by Experimental and Computational Approaches
    Bulitta, Jurgen B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (06) : 1426 - 1428
  • [34] RATIONAL APPROACHES TO THE DESIGN OF MECHANISM-BASED INHIBITORS OF S-ADENOSYLHOMOCYSTEINE HYDROLASE
    YUAN, CS
    LIU, SM
    WNUK, SF
    ROBINS, MJ
    BORCHARDT, RT
    NUCLEOSIDES & NUCLEOTIDES, 1995, 14 (3-5): : 439 - 447
  • [35] Cancer Cachexia: Traditional Therapies and Novel Molecular Mechanism-Based Approaches to Treatment
    Kumar, Nagi B.
    Kazi, Aslam
    Smith, Tiffany
    Crocker, Theresa
    Yu, Daohai
    Reich, Richard R.
    Reddy, Kiran
    Hastings, Sally
    Exterman, Martine
    Balducci, Lodovico
    Dalton, Kyle
    Bepler, Gerold
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2010, 11 (3-4) : 107 - 117
  • [36] Targeting transthyretin - Mechanism-based treatment approaches and future perspectives in hereditary amyloidosis
    Dohrn, Maike F.
    Ihne, Sandra
    Hegenbart, Ute
    Medina, Jessica
    Zuchner, Stephan L.
    Coelho, Teresa
    Hahn, Katrin
    JOURNAL OF NEUROCHEMISTRY, 2021, 156 (06) : 802 - 818
  • [37] Cancer risk reduction through mechanism-based molecular design of chemicals
    Lai, DY
    Woo, YT
    Argus, MF
    Arcos, JC
    DESIGNING SAFER CHEMICALS: GREEN CHEMISTRY FOR POLLUTION PREVENTION, 1996, 640 : 62 - 73
  • [38] The challenge of mechanism-based modeling in risk assessment for neurobehavioral end points
    Hattis, D
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1996, 104 : 381 - 390
  • [39] Risk Assessment of Mechanism-Based Inactivation in Drug-Drug Interactions
    Fujioka, Yasushi
    Kunze, Kent L.
    Isoherranen, Nina
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (09) : 1653 - 1657
  • [40] MECHANISM-BASED BIOMARKERS AND THE TRANSFORMATION OF DIAGNOSIS AND RISK ASSESSMENT OF HERBAL HEPATOTOXICITY
    Lin, Ge
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S17 - S17
12345